BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35574953)

  • 1. Ultrashort Door-to-Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019.
    Mikulík R; Bar M; Bělašková S; Černík D; Fiksa J; Herzig R; Jura R; Jurák L; Klečka L; Neumann J; Ostrý S; Šaňák D; Ševčík P; Škoda O; Šrámek M; Tomek A; Václavík D;
    J Am Heart Assoc; 2022 May; 11(10):e023524. PubMed ID: 35574953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of prehospital intervention based on emergency medical services on door-to-needle time of thrombolysis in acute ischemic stroke].
    Wang Y; Zhang C; Sun W; Hu X; Lyu Z; Liu W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):667-670. PubMed ID: 30045795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote intracerebral haemorrhage post intravenous thrombolysis: experience from an Australian stroke centre.
    Gao Y; Churilov L; Teo S; Yan B
    J Clin Neurosci; 2015 Feb; 22(2):352-6. PubMed ID: 25304437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three easily-implementable changes reduce median door-to-needle time for intravenous thrombolysis by 23 minutes.
    Tran D; Zhu Z; Shafie M; Abcede H; Stradling D; Yu W
    BMC Neurol; 2019 Nov; 19(1):300. PubMed ID: 31771530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis in Stroke within 30 Minutes: Results of the Acute Brain Care Intervention Study.
    Zinkstok SM; Beenen LF; Luitse JS; Majoie CB; Nederkoorn PJ; Roos YB
    PLoS One; 2016; 11(11):e0166668. PubMed ID: 27861540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
    Tanaka K; Matsumoto S; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104305. PubMed ID: 31405791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational changes aiming to reduce iv tPA door-to-needle time.
    Thortveit ET; Bøe MG; Ljøstad U; Mygland A; Tveiten A
    Acta Neurol Scand; 2014 Oct; 130(4):248-52. PubMed ID: 24256431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
    Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
    JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.
    Dorado L; Ahmed N; Thomalla G; Lozano M; Malojcic B; Wani M; Millán M; Tomek A; Dávalos A
    Stroke; 2017 Mar; 48(3):720-725. PubMed ID: 28174326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
    Tong X; George MG; Yang Q; Gillespie C
    Int J Stroke; 2014 Aug; 9(6):728-34. PubMed ID: 24024962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation-based team training improves door-to-needle time for intravenous thrombolysis.
    Svobodová V; Maršálková H; Volevach E; Mikulík R
    BMJ Open Qual; 2023 Feb; 12(1):. PubMed ID: 36810293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Even Faster Door-to-Alteplase Times and Associated Outcomes in Acute Ischemic Stroke.
    Jung S; Rosini JM; Nomura JT; Caplan RJ; Raser-Schramm J
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104329. PubMed ID: 31607439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis.
    Mullen MT; Pisapia JM; Tilwa S; Messé SR; Stein SC
    Stroke; 2012 Sep; 43(9):2350-5. PubMed ID: 22811451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register.
    Keselman B; Cooray C; Vanhooren G; Bassi P; Consoli D; Nichelli P; Peeters A; Sanak D; Zini A; Wahlgren N; Ahmed N; Mazya MV
    Eur J Neurol; 2019 Aug; 26(8):1091-1097. PubMed ID: 30793434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing in-hospital delay in treatment with intravenous thrombolysis.
    Mikulík R; Kadlecová P; Czlonkowska A; Kobayashi A; Brozman M; Svigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Krespi Y; Ahmed N;
    Stroke; 2012 Jun; 43(6):1578-83. PubMed ID: 22426311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
    Lei YS; Li H; Lei JY; Li SX; Li DF
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in Door-to-Needle Time in Patients with Acute Ischemic Stroke via a Simple Stroke Activation Protocol.
    Tan BYQ; Ngiam NJH; Sunny S; Kong WY; Tam H; Sim TB; Leong BSH; Bhartendu C; Paliwal PR; Seet RCS; Chan BPL; Teoh HL; Sharma VK; Yeo LLL
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1539-1545. PubMed ID: 29422380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors.
    Van Schaik SM; Scott S; de Lau LM; Van den Berg-Vos RM; Kruyt ND
    Cerebrovasc Dis Extra; 2015; 5(2):75-83. PubMed ID: 26265910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
    Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.